Systemic lupus erythematosus in a pediatric patient with congenital acquired immunodeficiency syndrome

Pediatric Infectious Disease Journal

Volumn 20, Issue 4, 2001, Pages 450-452

  O'Keefe, Kathleen ^a,b   Edelheit, Barbara ^a   Onel, Karen ^a   Tantawi, Mohamed ^a   Johann Liang, Rosemary ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Blythedale Children's Hospital   (United States)

Author keywords

Children; Human immunodeficiency virus; Systemic lupus erythematosus; Vasculitis

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CORTICOSTEROID; DIDANOSINE; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CASE REPORT; COMORBIDITY; CORTICOSTEROID THERAPY; DRUG RESPONSE; FEMALE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; NONHUMAN; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; CHILD, PRESCHOOL; FEMALE; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; VASCULITIS;

EID: 0035071571     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200104000-00018     Document Type: Article

References (13)

1. Infections and systemic vasculitis
2. Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus
3. SLE nephropathy in a patient with HIV infection: Case report and review of the literature
4. Renal disease in children with acquired immunodeficiency syndrome
5. Coexistence of AIDs and lupus nephritis: A case report
6. Pharmacoepidemiology of adverse drug reactions in hospitalized patients with human immunodeficiency virus disease
7. Zidovudine-induced leukocytoclastic vasculitis
8. Hypersensitivity of zidovudine: Report of a case of anaphylaxis and review of the literature
9. The spectrum and treatment of virus-associated vasculitides
10. The 1982 revised criteria for the classification of systemic lupus erythematosus
11. Rheumatologic manifestations of human immunodeficiency virus infection
12. Immunological effects of antiretroviral therapy
13. HIV-associated bacteremia: How it has changed in the highly active antiretroviral therapy (HAART) era